By rray, 27 April, 2023 Exclude Patient Type Detail Header No Detail Type Text Detail Text Bavencio avelumab Imfinzi durvalumab Imjudo tremelimumab Jemperli dostarlimab Keytruda pembrolizumab Libtayo cemiplimab Opdivo nivolumab Opdualag nivolumab relatlimab Tecentriq atezolizumab Yervoy ipilimumab Patient Type Detail Header (Long) View checkpoint inhibitors drug info: